Here are relevant reports on : in-vitro-diagnostics-ivd-market
-
Latin America In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Disease) - Forecast to 2031
The Latin America in vitro diagnostics (IVD) market, valued at USD 5.48 billion in 2025, stood at USD 5.87 billion in 2026 and is projected to advance at a resilient CAGR of 6.7% from 2026 to 2031, culminating in a forecasted valuation of USD 8.13 billion by the end of the period. The increasing demand for diagnostic services, along with the growing need for routine and specialized testing, is driving the market. Investments in lab infrastructure, combined with the adoption of automated and standardized diagnostic procedures, contribute to increasing test volumes in both the public and private healthcare sectors.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) - Forecast to 2031
The Asia Pacific in vitro diagnostics market is valued at an estimated USD 29.27 billion in 2026 and is projected to reach USD 45.11 billion by 2031 at a CAGR of 9.0% during the forecast period. The Key Players F. Hoffmann-La Roche Ltd (Switzerland), Abbott (US), Danaher (US), Sysmex Corporation (Japan), Shenzhen Mindray Bio-Medical Electronics Co., (China)., Siemens Healthineers AG (Germany), bioMérieux (France), Illumina, Inc. (US), Becton, Dickinson and Company (US), and QuidelOrtho Corporation (US).
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
US In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) - Forecast to 2031
US In Vitro Diagnostics market, valued at USD 37.43 billion in 2025, stood at USD 40.15 billion in 2026 and is projected to advance at a resilient CAGR of 7.3% from 2025 to 2031, culminating in a forecasted valuation of USD 57.18 billion by the end of the period. This growth is primarily driven by the rising prevalence of chronic and infectious diseases, the increasing demand for early and accurate diagnostic testing, the widespread adoption of advanced molecular diagnostic technologies, the growth in point-of-care testing, and continuous innovations in diagnostic instruments and assays.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) & Region- Global Forecast to 2030
The global in vitro diagnostics market, valued at USD 101.05billion in 2024, stood at USD 109.06 billion in 2025 and is projected to advance at a resilient CAGR of 7.6% from 2025 to 2030, culminating in a forecasted valuation of USD 157.63 billion by the end of the period. Market growth is primarily fueled by the rising prevalence of chronic and infectious diseases, increasing demand for rapid and accurate diagnostic solutions, and the growing shift toward personalized medicine.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Europe In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) - Forecast to 2031
The Europe in vitro diagnostics (IVD) market, valued at USD 31.43 billion in 2025, stood at USD 33.83 billion in 2026 and is projected to advance at a resilient CAGR of 7.9% from 2026 to 2031, culminating in a forecasted valuation of USD 49.49 billion by the end of the period. Market growth is driven by rising diagnostic test volumes across national healthcare systems, broader adoption of population-based screening programs, and increasing emphasis on standardized disease monitoring.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
IVD Contract Manufacturing Services Market - Global Forecast to 2024
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Medical Device Testing Market by Service (Testing, Inspection, Certification), Sourcing (In-house, Outsourced), Technology (Active Implant, Active, Non-active, IVD, Ophthalmic, Orthopedic & Dental, Vascular), Class (I, II, III) – Global Forecast to 2028
The global medical device testing market is expected to grow from USD 10.6 billion in 2023 to USD 13.5 billion by 2028, at a compound annual growth rate (CAGR) of 4.9% during the forecast period.The Key players Eurofins Scientific (Luxembourg), Intertek Group plc (UK), SGS Société Générale de Surveillance SA. (Switzerland), Bureau Veritas (France), TÜV SÜD (Germany).
- Published: October 2023
- Price: $ 4950
- TOC Available:
-
Medical Device Engineering Market by Service Type (Product Support & Maintenance, Prototyping, Electronic Engineering, Connectivity and Mobility Services), Device Type (Patient Monitoring, & Life Support, Medical Lasers, IVD) - Global Forecast to 2029
The global medical device engineering market, valued at US$8.2 billion in 2023, stood at US$9.0 billion in 2024 and is projected to advance at a resilient CAGR of 10.1% from 2024 to 2029, culminating in a forecasted valuation of US$14.7 billion by the end of the period. The growth of the market is driven by a host of factors: rapid advancements in medical technology, an increased incidence of chronic diseases, and stringent regulatory requirements.
- Published: August 2024
- Price: $ 4950
- TOC Available:
-
Medical Device Contract Manufacturing Market by Device Type (IVD, Cardiovascular, Orthopedic, Dental), Class of Device (Class I, II, III), Service (Device Development & Manufacturing, Packaging & Assembly, Quality Management) - Global Forecast to 2030
The global medical device contract manufacturing market, valued at US$78.58 billion in 2024, stood at US$83.77 billion in 2025 and is projected to advance at a resilient CAGR of 10.9% from 2025 to 2030, culminating in a forecasted valuation of US$140.84 billion by the end of the period.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Legionella Testing Market by Test Type (Culture, Urinary Antigen Test, DFA, PCR), Application (Water & IVD Testing (Urine, Blood)), End User (Hospitals, Clinics, Diagnostic Labs, Water Treatment Industries), Region - Global Forecast to 2027
The global legionella testing market growth is primed to transition from $296.0 million in 2022 to $439.0 million by 2027, showcasing a strong CAGR of 8.2%. The rising geriatric population, combined with the rising prevalence of legionella-related illness and rising demand for rapid diagnostics, is driving growth in this market.
- Published: August 2022
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
